Literature DB >> 26983734

Standardized Methods for Detection of Poliovirus Antibodies.

William C Weldon1, M Steven Oberste2, Mark A Pallansch2.   

Abstract

Testing for neutralizing antibodies against polioviruses has been an established gold standard for assessing individual protection from disease, population immunity, vaccine efficacy studies, and other vaccine clinical trials. Detecting poliovirus specific IgM and IgA in sera and mucosal specimens has been proposed for evaluating the status of population mucosal immunity. More recently, there has been a renewed interest in using dried blood spot cards as a medium for sample collection to enhance surveillance of poliovirus immunity. Here, we describe the modified poliovirus microneutralization assay, poliovirus capture IgM and IgA ELISA assays, and dried blood spot polio serology procedures for the detection of antibodies against poliovirus serotypes 1, 2, and 3.

Entities:  

Keywords:  Antibodies; Dried blood spot; ELISA; IPV; IgA; IgM; Neutralization; OPV; Poliovirus

Mesh:

Substances:

Year:  2016        PMID: 26983734     DOI: 10.1007/978-1-4939-3292-4_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  57 in total

1.  Biocompatible near-infrared quantum dots delivered to the skin by microneedle patches record vaccination.

Authors:  Kevin J McHugh; Lihong Jing; Sean Y Severt; Mache Cruz; Morteza Sarmadi; Hapuarachchige Surangi N Jayawardena; Collin F Perkinson; Fridrik Larusson; Sviatlana Rose; Stephanie Tomasic; Tyler Graf; Stephany Y Tzeng; James L Sugarman; Daniel Vlasic; Matthew Peters; Nels Peterson; Lowell Wood; Wen Tang; Jihyeon Yeom; Joe Collins; Philip A Welkhoff; Ari Karchin; Megan Tse; Mingyuan Gao; Moungi G Bawendi; Robert Langer; Ana Jaklenec
Journal:  Sci Transl Med       Date:  2019-12-18       Impact factor: 17.956

2.  Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial.

Authors:  Cynthia J Snider; Khalequ Zaman; Concepcion F Estivariz; Mohammad Yunus; William C Weldon; Kathleen A Wannemuehler; M Steven Oberste; Mark A Pallansch; Steven Gf Wassilak; Tajul Islam A Bari; Abhijeet Anand
Journal:  Lancet       Date:  2019-05-16       Impact factor: 79.321

3.  Estimating population immunity to poliovirus in Jordan's high-risk areas.

Authors:  Noha H Farag; Kathleen Wannemuehler; William Weldon; Ali Arbaji; Adel Belbaisi; Najwa Khuri-Bulos; Derek Ehrhardt; Mohammad Ratib Surour; Nabil Sabri ElhajQasem; Mohammad Mousa Al-Abdallat
Journal:  Hum Vaccin Immunother       Date:  2019-11-05       Impact factor: 3.452

4.  Extended delivery of vaccines to the skin improves immune responses.

Authors:  Jessica C Joyce; Hila E Sella; Heather Jost; Matthew J Mistilis; E Stein Esser; Pallab Pradhan; Randall Toy; Marcus L Collins; Paul A Rota; Krishnendu Roy; Ioanna Skountzou; Richard W Compans; M Steven Oberste; William C Weldon; James J Norman; Mark R Prausnitz
Journal:  J Control Release       Date:  2019-05-06       Impact factor: 9.776

5.  Seroprevalence of poliovirus antibodies in the Kansas City metropolitan area, 2012-2013.

Authors:  Gregory S Wallace; Barbara A Pahud; William C Weldon; Aaron T Curns; M Steven Oberste; Christopher J Harrison
Journal:  Hum Vaccin Immunother       Date:  2017-01-06       Impact factor: 3.452

6.  Thin silk fibroin films as a dried format for temperature stabilization of inactivated polio vaccine.

Authors:  Jordan A Stinson; Carter R Palmer; David P Miller; Adrian B Li; Kandice Lightner; Heather Jost; William C Weldon; M Steven Oberste; Jonathan A Kluge; Kathryn M Kosuda
Journal:  Vaccine       Date:  2020-01-17       Impact factor: 3.641

7.  Dried blood spots: An evaluation of utility in the field.

Authors:  Xu Su; Bradley F Carlson; Xiexiu Wang; Xiaoyan Li; Ying Zhang; JoLynn P Montgomery; Yaxing Ding; Abram L Wagner; Brenda Gillespie; Matthew L Boulton
Journal:  J Infect Public Health       Date:  2017-09-28       Impact factor: 3.718

8.  Poliovirus immunity among children under five years-old in accessible areas of Afghanistan, 2013.

Authors:  Christopher H Hsu; Kathleen A Wannemuehler; Sajid Soofi; Mohd Mashal; Imtiaz Hussain; Zulfiqar A Bhutta; Larin McDuffie; William Weldon; Noha H Farag
Journal:  Vaccine       Date:  2019-02-16       Impact factor: 3.641

9.  Immunogenicity of Different Routine Poliovirus Vaccination Schedules: A Randomized, Controlled Trial in Karachi, Pakistan.

Authors:  Ali F Saleem; Ondrej Mach; Mohammad T Yousafzai; Asia Khan; William C Weldon; M Steven Oberste; Syed S Zaidi; Muhammad M Alam; Farheen Quadri; Roland W Sutter; Anita K M Zaidi
Journal:  J Infect Dis       Date:  2018-01-17       Impact factor: 5.226

Review 10.  Progress of polio eradication and containment requirements after eradication.

Authors:  M Steven Oberste
Journal:  Transfusion       Date:  2018-12       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.